NASDAQ:SRZN

Surrozen (SRZN) Stock Price, News & Analysis

Surrozen logo
$28.46 -2.21 (-7.21%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$28.46 -0.01 (-0.02%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Surrozen Stock (NASDAQ:SRZN)

Advanced

Key Stats

Today's Range
$28.25
▼
$30.34
50-Day Range
$16.16
▼
$33.68
52-Week Range
$12.79
▼
$37.83
Volume
148,849 shs
Average Volume
280,469 shs
Market Capitalization
$542.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$61.75
Consensus Rating
Moderate Buy

Company Overview

Surrozen, Inc. is a biotechnology company developing antibody-based medicines designed to activate the Wnt signaling pathway, which plays a role in tissue growth and repair. The company uses its proprietary platform to develop therapies intended to stimulate regeneration in specific tissues while limiting effects elsewhere in the body.

Surrozen’s research has included candidates aimed at liver disease and inflammatory bowel disease, including SZN-043 and SZN-1326. Its work focuses on advancing potential treatments through research and clinical development; the company’s products are investigational and are not approved medicines.

Founded in 2016, Surrozen is based in South San Francisco, California. Its programs and platform reflect a focus on applying antibody engineering to regenerative medicine.

AI Generated. May Contain Errors.

Surrozen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

SRZN MarketRank™: 
2.19276094276 of 5 stars

Surrozen scored higher than 44% of companies evaluated by MarketBeat, and ranked 567th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surrozen has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Surrozen has a consensus price target of $61.75, representing about 117.0% upside from its current price of $28.46.

  • Amount of Analyst Coverage

    Surrozen has only been the subject of 4 research reports in the past 90 days.

  • Read more about Surrozen's stock forecast and price target.
  • Earnings Growth

    Earnings for Surrozen are expected to grow in the coming year, from ($6.85) to ($4.71) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surrozen is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surrozen is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    40.82% of the float of Surrozen has been sold short.
  • Short Interest Ratio / Days to Cover

    Surrozen has a short interest ratio ("days to cover") of 8.51.
  • Change versus previous month

    Short interest in Surrozen has recently increased by 3.31%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Surrozen does not currently pay a dividend.

  • Dividend Growth

    Surrozen does not have a long track record of dividend growth.

  • News Sentiment

    Surrozen has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Surrozen this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for SRZN on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Surrozen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    31.74% of the stock of Surrozen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    66.57% of the stock of Surrozen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Surrozen's insider trading history.
Receive SRZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surrozen and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SRZN Stock News Headlines

Guggenheim Names Top Biotech Stock Pick Following JNJ Latest Deal
HC Wainwright Comments on Surrozen FY2026 Earnings
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
Surrozen (NASDAQ:SRZN) Stock Rating Lowered by Wall Street Zen
Surrozen Prices $60 Million Offering
See More Headlines

SRZN Stock Analysis - Frequently Asked Questions

Surrozen's stock was trading at $22.60 at the beginning of 2026. Since then, SRZN stock has increased by 25.9% and is now trading at $28.46.

Surrozen, Inc. (NASDAQ:SRZN) released its earnings results on Monday, November, 9th. The company reported ($11.02) EPS for the quarter, missing the consensus estimate of ($1.10) by $9.92.

Surrozen's stock reverse split before market open on Thursday, December 14th 2023.The 1-15 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Top institutional investors of Surrozen include Integral Health Asset Management LLC (2.80%), State Street Corp (1.17%), Regents of The University of California (1.15%) and Goldman Sachs Group Inc. (0.97%). Insiders that own company stock include Group Gp Lp Column III, Tim Kutzkey, Tcg Crossover Gp Ii, Llc, Yang Li, Charles O Williams and Craig C Parker.
View institutional ownership trends
.

Shares of SRZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/09/2026
Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SRZN
CIK
1824893
Fax
N/A
Employees
44
Year Founded
2016

Price Target and Rating

High Price Target
$80.00
Low Price Target
$51.00
Potential Upside/Downside
+117.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($43.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$242.03 million
Net Margins
-2,885.33%
Pretax Margin
-3,706.41%
Return on Equity
N/A
Return on Assets
-112.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.56
Quick Ratio
7.56

Sales & Book Value

Annual Sales
$10.53 million
Price / Sales
51.53
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($17.61) per share
Price / Book
-1.62

Miscellaneous

Outstanding Shares
19,062,000
Free Float
13,012,000
Market Cap
$542.50 million
Optionable
Optionable
Beta
0.51

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:SRZN) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners